Eligibility and Gudlines
Eligibility and related guidelines: Investigators eligible for pilot and feasibility funding fall into three categories: (1) new investigators without current or past NIH research support as a principal investigator (current or past support from other sources should have been modest); (2) established investigators with no previous work in diabetes who wish to apply their expertise to a problem in this area; and (3) established investigators in diabetes who propose testing innovative ideas that represent clear departure from ongoing research interests. It is expected that the majority of the investigators will fall into the first category. All eligible investigators, however, must have faculty appointments and be independent investigators. Postdoctoral fellows or their equivalent are not eligible. Each pilot and feasibility study proposal should state clearly the justification for eligibility of the investigator under one of the above three criteria.
A proposed pilot and feasibility study should present a testable hypothesis and clearly delineate the question being asked, detail the procedures to be followed, and discuss how the data will be analyzed. It must be on a topic related to the objectives of the Core Center.
Projects should be submitted using a Form PHS 398. Projects should begin with a face page, abstract, and budget pages, followed by information requested in Sections A through I of the instructions for Form PHS 398. They should be submitted using the NIH research project application format, but the description of the research plan (Specific Aims, Background & Significance, Preliminary Studies/Progress Report, Research Design & Methods) sections should be limited to a maximum of five pages. There are no page limitations for the Human Subjects, Vertebrate Animal, Selective Agent, Literature Cited, Multiple PI, Consortium and Resource Sharing sections. Projects will be reviewed for scientific merit and eligibility by an internal executive committee and those selected will be submitted as part of the larger DERC application.
Should you wish to discuss this, please contact Dr. Pessin at 444-3083 (pessin@pharm.stonybrook.edu). Please e-mail electronic (pdf) files of your application to lucy.kenny@stonybrook.edu by 10/15/06. Applications submitted after this deadline will not be considered.
Lucy E. Kenny
Department of Planning
Stony Brook University Hospital
188 Belle Meade Road
E. Setauket NY 11733-9109
Telephone: (631) 638-4005
